Plain-English translation of NCT04882904 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
ActiSLA is a research study designed to understand how muscle activity changes in people with amyotrophic lateral sclerosis (ALS). The researchers will use a special wearable device called Actimyo to continuously measure your movement and activity in your daily life, combined with regular clinic visits where you'll complete standard ALS tests and exams.
ALS causes progressive muscle weakness, but doctors don't have good ways to continuously track how quickly muscles are deteriorating in everyday life. This study aims to fill that gap by using wearable technology to get a clearer picture of disease progression, which could help doctors better understand the illness and develop better treatments.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic every three months for one year (four visits total). At each visit, you'll have a physical exam, several muscle strength and movement tests, and answer some questionnaires about your symptoms. After each visit, you'll wear the Actimyo activity sensor for one month while going about your daily life — it tracks your movement continuously to show how your muscle activity changes over time.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Belgium